Results 321 to 330 of about 8,503,937 (347)
Some of the next articles are maybe not open access.
Testosterone and cardiovascular risk
Internal and Emergency Medicine, 2013Cardiovascular (CV) disease is one of the most common causes of death in the western populations and, nowadays, its incidence is increasing even in the developing countries; although CV disease affects both sexes, it is more frequent in males in whom it shortens the average life expectancy.
Tirabassi G+7 more
openaire +4 more sources
Fibrinogen and cardiovascular risk
Journal of Cardiovascular Risk, 1995Ischaemic heart disease and stroke are the major causes of death in the Western world. Established risk factors such as smoking, hypertension and hypercholesterolaemia explain only some of these events. Most myocardial infarctions and cardiac deaths are precipitated by acute occluding coronary thrombi, and it has been known for some time that ...
G Assmann, Joachim Heinrich
openaire +3 more sources
Flaxseed and Cardiovascular Risk
Nutrition Reviews, 2004Flaxseed has recently gained attention in the area of cardiovascular disease primarily because it is the richest known source of both alpha-linolenic acid (ALA) and the phytoestrogen, lignans, as well as being a good source of soluble fiber. Human studies have shown that flaxseed can modestly reduce serum total and low-density lipoprotein cholesterol ...
Philippe O. Szapary, LeAnne T. Bloedon
openaire +3 more sources
Rosiglitazone and cardiovascular risk
Current Atherosclerosis Reports, 2008A meta-analysis of 42 clinical trials suggested that rosiglitazone, a widely used thiazolidinedione, was associated with a 43% greater risk of myocardial infarction (P = 0.03) and a 64% greater risk of cardiovascular death (P = 0.06). However, a number of criticisms have been raised that potentially undermine the conclusions of this analysis.
Sanjay Kaul, George A. Diamond
openaire +4 more sources
Estimating Cardiovascular Risk
Archives of Internal Medicine, 2008Copyright © 2008 American Medical Association. All rights reserved. ; Bastian M.
Seidel, Bastian Manfred+1 more
openaire +3 more sources
Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.
Journal of the American Medical Association (JAMA), 2020Importance Perioperative cardiovascular complications occur in 3% of hospitalizations for noncardiac surgery in the US. This review summarizes evidence regarding cardiovascular risk assessment prior to noncardiac surgery.
N. Smilowitz, J. Berger
semanticscholar +1 more source
Hyperglycaemia and cardiovascular risk
Acta Diabetologica, 2003Cardiovascular diseases represent, today, the principal cause of mortality in the general population, especially in subjects with type 2 diabetes mellitus. In these patients the risk of death from cardiovascular diseases is equal to that of non-diabetic subjects with a previous episode of myocardial infarction.
Palumbo F+3 more
openaire +4 more sources
Predicting Cardiovascular Risk Factors from Retinal Fundus Photographs using Deep Learning
arXiv.org, 2017Traditionally, medical discoveries are made by observing associations and then designing experiments to test these hypotheses. However, observing and quantifying associations in images can be difficult because of the wide variety of features, patterns ...
R. Poplin+7 more
semanticscholar +1 more source
Perception of cardiovascular risk and comparison with actual cardiovascular risk
European Journal of Cardiovascular Prevention & Rehabilitation, 2009Current guidelines recommend treating patients according to their absolute cardiovascular disease (CVD) risk. We examined perception of CVD risk among adults and how it can be compared with actual CVD risk.The perception of CVD risk was assessed by two questions asking about participants' 'risk to get a heart attack or a stroke over the next 10 years ...
Heba Alwan+4 more
openaire +3 more sources
Platelets and cardiovascular risk
Acta Cardiologica, 2017Atherosclerosis and its late sequels are still the number one cause of death in Western societies. Platelets are a driving force not only during the genesis of atherosclerosis, but especially in its late stages, as evidenced by complications such as arterial thrombosis, myocardial infarction, and ischaemic stroke.
Barbara Renga, Franco Scavizzi
openaire +3 more sources